AMERIPRISE FINANCIAL INC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in ARQT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,395,438
-$474,467 QoQ
Shares Held
101,674
+2.9% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 77.63833428408444.ToString("F0")%
None 22.361665715915574.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. ARQT ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in ARQT
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,395,438 | 101,674 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,869,905 | 98,826 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,869,635 | 99,185 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,388,596 | 99,044 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,773,246 | 113,379 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,949,209 | 139,929 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $830,181 | 89,267 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $719,874 | 77,406 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $930,945 | 93,940 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,487,043 | 1,079,580 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $3,212,105 | 337,052 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,402,074 | 854,734 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $12,041,604 | 813,622 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,510,895 | 654,678 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,596,645 | 544,188 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,286,845 | 430,262 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,488,198 | 216,403 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,649,016 | 362,035 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,684,675 | 354,880 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,176,682 | 317,203 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,238,241 | 115,117 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,334,267 | 284,446 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,407,294 | 278,019 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,582,282 | 254,439 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||